Yüklüyor......

Effectiveness of BRAF inhibitors in patients with BRAF V600 mutation positive glioma: a systematic review

BACKGROUND: BRAF inhibitor treatment with vemurafenib and dabrafenib have produced significant increases in median overall survival for BRAF V600 mutation-positive melanoma patients and are in wide clinical use. BRAF inhibitors have also been used in an ad hoc fashion in BRAF V600 mutation-positive...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Yao, Ian, Dawson, Sarah, Higgins, Julian, McGuinness, Luke, McAleenan, Alexandra, Kurian, Kathreena M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6789952/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz167.059
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!